The Cooper Companies, Inc.

The Cooper Companies, Inc. (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California, founded in 1958, with approximately 16,000 full-time employees and a market capitalization of approximately $13.75 billion. The company operates through two primary business segments: CooperVision, a leading manufacturer of contact lenses — including spherical, toric, multifocal, and myopia-control lenses such as the FDA-approved MiSight brand — serving markets across the Americas, Europe, the Middle East, Africa, and Asia Pacific; and CooperSurgical, which is dedicated to women's and family health, offering a broad portfolio of medical devices, fertility consumables and equipment, genomic and genetic testing services, and contraceptive products such as the PARAGARD IUD. The company distributes its products through eye care and healthcare professionals, hospitals, fertility clinics, distributors, and retail chains worldwide, benefiting from a recurring revenue model driven by regular contact lens replacement and ongoing clinical procedure demand. Under the leadership of CEO Albert G. White, Cooper Companies continues to expand its market presence through organic growth and strategic acquisitions across its two specialized healthcare niches.